Details of the Drug
General Information of Drug (ID: DM7KDQV)
Drug Name |
2-Hex-5-enyl-5-non-8-enyl-pyrrolidine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-Hex-5-enyl-5-non-8-enyl-pyrrolidine; CHEMBL14599; 2-(5-Hexenyl)-5-(8-nonenyl)pyrrolidine; 100594-86-3; 2-Hex-5-enyl-5-non-8-enylpyr; ACMC-20m3ob; Pyrrolidine, 2-(5-hexenyl)-5-(8-nonenyl)-; CTK0I4208; YCQNSAJAZIVRFR-UHFFFAOYSA-N; AC1L4819; BDBM50284428
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 277.5 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 6.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 13 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||